We have previously shown that EGCG suppresses melanoma tumor growth by activating the intercellular signaling pathway, cAMP/protein kinase A (PKA)/protein phosphatase 2A (PP2A), as an agonist of 67LR23. Here, PTPA is linked to melanoma.